GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus
Abstract Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a tick-borne virus that causes severe hemorrhagic disease in humans. There is a great need for effective vaccines and therapeutics against CCHFV for humans, as none are currently internationally approved. Recently, a monoclonal antibody again...
Main Authors: | Gabrielle Scher, Dennis A. Bente, Megan C. Mears, Maria N. B. Cajimat, Matthias J. Schnell |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-023-00663-5 |
Similar Items
-
In silico Design of a Crimean-Congo Hemorrhagic Fever Virus Glycoprotein Multi-Epitope Antigen for Vaccine Development
by: Megan C. Mears, et al.
Published: (2022-10-01) -
Crimean–Congo Hemorrhagic Fever Virus: Progress in Vaccine Development
by: Aykut Ozdarendeli
Published: (2023-08-01) -
Crimean-Congo Hemorrhagic Fever Virus, Greece
by: Anna Papa, et al.
Published: (2014-02-01) -
Crimean-Congo Hemorrhagic Fever
by: Sümeyye KAZANCIOĞLU, et al.
Published: (2017-12-01) -
The world areal of Crimean-Congo hemorrhagic fever virus
by: S. Ye. Smirnova
Published: (2006-12-01)